← All reports

The FDA should not overlook unproven peptides due to their lack of proven safety and efficacy.

HealthcareLegal IssuesOct 16, 2026score 0.962 posts · 2 replies across 2 instances
The thread discusses RFK Jr.'s proposal for the FDA to overlook unproven peptides, contrasting with FDA scientists' assertion that these drugs lack proven safety and efficacy. This highlights a conflict between regulatory oversight and alternative medical claims.

Claims

The FDA should not overlook unproven peptides due to their lack of proven safety and efficacy.
Parent: HealthcareEntity: FDASub-entity: Regulatory OversightImpact: negativeDate: Oct 16, 2026Target: The FDA's regulatory oversight of unproven peptides

Source posts

@[email protected]
RFK Jr. proposes FDA look the other way on unproven peptides, report says FDA scientists said none of the popular drugs have been proven safe or effective. https://arstechnica.com/health/2026/10/rfk-jr-proposes-fda-look-the-other-way-on-unproven-peptides-report-says/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social
14 boosts · 12 favs · 2 replies · Oct 16, 2026
@[email protected]
#ArsTechnica #Tech RFK Jr. proposes FDA look the other way on unproven peptides, report says https://arstechni.ca/kAvq
0 boosts · 0 favs · 0 replies · Oct 16, 2026
#arstechnica#tech